semaglutide and cardiovascular disease outcomes align more closely with attained dose than achieved weight loss Heart health: Wegovy may lower

Gip tr nm tn nhang hiu qu

Some, such as semaglutide and tirzepatide, are now commonly prescribed for weight management

The main purpose of weight loss medicine like semaglutide is to activate a hormone called GLP-1 (glucagon-like peptide-1)

If the FDA approves tirzepatide for a new indication that is not weight loss (for example, cardiovascular risk reduction, sleep apnea, or fatty liver disease), and that indication is not explicitly excluded by statute, TRICARE could cover tirzepatide for that indication

One drug may be prescribed over the other depending on individual needs, preferences, and overall health

If you have questions about compounded medications, the approval process, testing requirements or licensing patients must contact their dispensing 3rd party pharmacy directly